Li Hong-Yu, Liu Jing, Liang Xiao-Cai, Wang Yi-Lin, Meng Yong-Cheng, Chen Wei-Cai, Huang Yong
Guangxi University of Chinese Medicine Nanning 530200, China.
Nanning Normal University Nanning 530001, China.
Zhongguo Zhong Yao Za Zhi. 2024 Jan;49(1):80-87. doi: 10.19540/j.cnki.cjcmm.20231013.101.
The animal species is one of the key factors affecting the quality of Bufonis Venenum. The quality of Bufonis Venenum derived from Bufo bufo gargarizans is significantly higher than that from B. melanostictus. Since Bufonis Venenum is from secretions, the conventional identification methods are difficult to identify the animal species due to the lack of the appearance and morphology of the animals. The rapid development of molecular identification technology has provided new methods for the identification of Bufonis Venenum. However, because of the low content and serve degradation of residual DNA in secretions, the research on the molecular identification of Chinese medicinal materials from secretions remains to be carried out. To understand the animal species of Bufonis Venenum, this study collected 83 samples of Bufonis Venenum, including 7 commercially available samples, 5 reference medicinal materials, and 71 animal samples from which Bufonis Venenum was prepared according to the method in the 2020 edition of the Chinese Pharmacopoeia. Different DNA extraction methods were used and compared, and the mitochondrial 16S rRNA gene fragments were amplified, on the basis of which the phylogenetic trees were built. Finally, molecular identification of the animal species of the samples was performed. The results showed that the DNA extracted from Bufonis Venenum by the reagent kit had good quality, and 16S rRNA sequences were successfully amplified from 80 out of the 83 samples. In addition, 71 16S rRNA sequences of the animal species of Bufonis Venenum were downloaded from GenBank. The phylogenetic trees constructed based on the neighbor-joining(NJ) method and the Bayesian inference(BI) method showed that the samples derived from B. bufo gargarizans and B. melanostictus were clustered into separate monophyletic clades, with the support of 100%(NJ) and 1.00(BI), respectively. The animal species of both commercially available samples and reference medicinal materials were B. bufo gargarizans. In conclusion, DNA can be extracted from Bufonis Venenum derived from secretions, and the 16S rRNA gene sequences can be amplified, which can be used for molecular identification of the animal species of Bufonis Venenum. The findings provide a reference for the quality control of Bufonis Venenum and the identification of animal species of medicinal materials derived from secretions.
动物种类是影响蟾酥质量的关键因素之一。中华大蟾蜍来源的蟾酥质量显著高于黑眶蟾蜍来源的蟾酥。由于蟾酥来自分泌物,传统鉴定方法因缺乏动物的外观和形态而难以鉴定动物种类。分子鉴定技术的快速发展为蟾酥的鉴定提供了新方法。然而,由于分泌物中残留DNA含量低且易降解,对来源于分泌物的中药材进行分子鉴定的研究仍有待开展。为了解蟾酥的动物种类,本研究收集了83份蟾酥样品,包括7份市售样品、5份对照药材以及71份按照《中国药典》2020年版方法制备蟾酥的动物样品。采用并比较了不同的DNA提取方法,扩增线粒体16S rRNA基因片段,并在此基础上构建系统发育树。最后,对样品的动物种类进行分子鉴定。结果表明,试剂盒提取的蟾酥DNA质量良好,83份样品中有80份成功扩增出16S rRNA序列。此外,从GenBank下载了71条蟾酥动物种类的16S rRNA序列。基于邻接法(NJ)和贝叶斯推断(BI)方法构建的系统发育树显示,中华大蟾蜍和黑眶蟾蜍来源的样品分别聚为独立的单系分支,支持率分别为100%(NJ)和1.00(BI)。市售样品和对照药材的动物种类均为中华大蟾蜍。综上所述,可从来源于分泌物的蟾酥中提取DNA并扩增16S rRNA基因序列,用于蟾酥动物种类的分子鉴定。研究结果为蟾酥的质量控制及来源于分泌物的药材动物种类鉴定提供参考。